Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
30.33 USD | +1.57% | -0.83% | -9.45% |
Apr. 22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
Mar. 28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.45% | 3.4B | |
+4.80% | 32.12B | |
+11.88% | 7B | |
+18.72% | 3.64B | |
-25.22% | 1.29B | |
-34.43% | 1.12B | |
+0.56% | 899M | |
-27.07% | 827M | |
-42.14% | 808M | |
-18.41% | 707M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Evolent Health, Inc. Revises Earnings Guidance for the Full Year of 2021